NCT01100658 · ADVERSE EVENTS

Adverse events

Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors · Source last updated 2015-03-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.

Collection time frame: Not reported
Other-event reporting threshold: 5%

No patients received treatment, therefore no adverse events were reported.

Participants affected / participants at risk, as reported
Safety group	Serious events	Other events	Deaths
Participant With Attention Deficit Participant previously had acute lymphoblastic leukemia or brain tumor to be treated with Methylphenidate or Placebo - Administered 1 capsule each day for 1 week, .3 mg/kg dose.	0 / 0	0 / 0	Not reported / Not reported

Group identifiers: EG000: Participant With Attention Deficit

Serious adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

Other reported adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

Complete source fields

description

No patients received treatment, therefore no adverse events were reported.

event Groups

description
Participant previously had acute lymphoblastic leukemia or brain tumor to be treated with Methylphenidate or Placebo - Administered 1 capsule each day for 1 week, .3 mg/kg dose.
id
EG000
other Num Affected
0
other Num At Risk
0
serious Num Affected
0
serious Num At Risk
0
title
Participant With Attention Deficit

frequency Threshold

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice